Leanne Embree
Impact in
- Biomaterials top 5%
- Nanoparticle-Based Drug Delivery
- Pharmaceutical Science top 5%
- Advanced Drug Delivery Systems
Papers in
-
- Antibiotics Pharmacokinetics and Efficacy 3
- Co-authors
- William L. Hunter (1 shared paper)Helen M. Burt (1 shared paper)Philip M. Toleikis (1 shared paper)Xichen Zhang (1 shared paper)Norma J. Hudon (5 shared papers)Karen A. Gelmon (4 shared papers)Marcel B. Bally (3 shared papers)Keith M. McErlane (3 shared papers)
- Journals
- Journal of Pharmaceutical and Biomedical Analysis (3 papers)Cancer Chemotherapy and Pharmacology (2 papers)Chirality (1 paper)Xenobiotica (1 paper)Colloids and Surfaces B Biointerfaces (1 paper)
- Partner nations
- CanadaUnited States
In The Last Decade
Leanne Embree
15 papers receiving 580 citations
Peers
Comparison fields: 5 of 73
- Biomaterials 268
- Pharmaceutical Science 71
- Oncology 144
- Hematology 54
- Analytical Chemistry 44
Countries citing papers authored by Leanne Embree
This map shows the geographic impact of Leanne Embree's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Leanne Embree with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Leanne Embree more than expected).
Fields of papers citing papers by Leanne Embree
This network shows the impact of papers produced by Leanne Embree. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Leanne Embree. The network helps show where Leanne Embree may publish in the future.
Co-authors
The 25 scholars most cited alongside Leanne Embree, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1999 | 232 | |
| 2 | 1999 | 104 | |
| 3 | 1998 | 40 | |
| 4 | 1993 | 38 | |
| 5 | 1997 | 34 | |
| 6 | 1997 | 28 | |
| 7 | 1999 | 26 | |
| 8 | 1993 | 25 | |
| 9 | 1996 | 24 | |
| 10 | 1995 | 19 | |
| 11 | 1989 | 15 | |
| 12 | 2000 | 14 | |
| 13 | 1990 | 8 | |
| 14 | 1990 | 4 | |
| 15 | Comparison of analysis of digoxin in cardiac patients by HPLC and RIA. | 1990 | 3 |
About Leanne Embree
Leanne Embree is a scholar working on Molecular Biology, Pharmacology, Oncology, Analytical Chemistry and Pathology and Forensic Medicine, having authored 15 papers that have together received 614 indexed citations. Recurring topics across this work include Analytical Methods in Pharmaceuticals (4 papers), Chemotherapy-induced organ toxicity mitigation (3 papers), Antibiotics Pharmacokinetics and Efficacy (3 papers), Corneal Surgery and Treatments (2 papers), Cancer Treatment and Pharmacology (2 papers), Hematopoietic Stem Cell Transplantation (2 papers), Analytical Chemistry and Chromatography (2 papers) and Lanthanide and Transition Metal Complexes (2 papers). The work is most often cited by research in Biomaterials (268 citations), Pharmaceutical Science (71 citations), Oncology (144 citations), Hematology (54 citations) and Analytical Chemistry (44 citations). Leanne Embree has collaborated with scholars based in Canada and United States. Frequent co-authors include William L. Hunter, Helen M. Burt, Philip M. Toleikis, Xichen Zhang, Norma J. Hudon, Karen A. Gelmon, Marcel B. Bally, Keith M. McErlane, Lawrence D. Mayer and L.D. Mayer. Their work appears in journals such as Journal of Pharmaceutical and Biomedical Analysis, Cancer Chemotherapy and Pharmacology, Chirality, Xenobiotica and Colloids and Surfaces B Biointerfaces.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.